Growing human cells in culture for research is one thing, but the isolation and culture of high-quality cells that will be re-injected back into the donor is quite another. Manipulation and expansion of cells in a clinical setting carries its own unique requirements and complications. Growth and survival needs to be optimized and quality control is paramount. Often only a single opportunity for successful treatment is possible, so chances of success need to be maximized in all respects, including high-yield isolation of good quality cells from patients, cell culture conditions, cell characterization, and reperfusion back into patients. During this webinar, we will broadly examine the process of immunotherapy as well as examine in more detail some of the most critical steps along the pathway to generating a therapeutic dose of modified cells.
During the webinar, the speakers will:
- Highlight how immunotherapy is currently being applied in the clinic and those factors important to generating high-quality cells
- Discuss the importance of perfusion to achieving high cell yield and its effect on cell markers and characteristics
- Focus on optimization of culture conditions when generating cells for reperfusion into patients
- Answer your questions live during the webinar!
To learn more about products or technologies related to this webinar, go to: www.gelifesciences.com/xuri